Superiority of Rituximab Over Mycophenolate Mofetil in the Treatment of Pemphigus Vulgaris: A Step Further in Its Approval as a First-Line Treatment?

J Cutan Med Surg. 2022 Jan-Feb;26(1):103-104. doi: 10.1177/12034754211035098. Epub 2021 Jul 28.
No abstract available

Keywords: mycophenolate mofetil; pemphigus; rituximab; treatment.

Publication types

  • Letter

MeSH terms

  • Humans
  • Immunologic Factors / therapeutic use*
  • Mycophenolic Acid / therapeutic use
  • Pemphigus / drug therapy*
  • Rituximab / therapeutic use*

Substances

  • Immunologic Factors
  • Rituximab
  • Mycophenolic Acid